ARCHIVES

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

This article is from The Cancer Letter archive.

Vol. 23 No. 7 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

Pryce Introduces Bill To Reimbuse For Orally Administered Cancer Drugs.

May 4, 2001

FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency

August 14, 1992

ACS Says 41 Percent Survive 5 Years

January 2, 1981

Mayo Clinic’s NCI Designation Extended To Arizona, Florida Sites

July 26, 2002

In Brief: NCI To File Heroin IND For Pain Control; Sen. Cranston To Keynote Meeting On Centers

March 31, 1978

NCI Advisors Approve Continuation Of Cancer Genome Atlas Network.

December 19, 2008